Although we have failed to isolate any hypomethylated fragment from patients who have arsenic induced cancer or persons having chronic high level of exposure with systemic manifestations, yet, there was number of subjects with p53 promoter hypomethylation in our previous study (Chanda et al.2006). The gene discussed is TP53; the disease is cancer.